Common Dreams, By: Jon Queally, 12/16/2013
What came first: the disorder, the cure, or the marketing campaign to sell both? In the case of medicating a generation of children who were said to be "unusually hyperactive," the answer to that question is addressed by an in-depth investigation by the New York Times on Monday showing that the meteoric rise of diagnoses of attention deficit hyperactivity disorder (A.D.H.D.)—a trend that spawned a pharmaceutical gold rush over the last twenty years—was, in fact, fueled by an industry-led marketing campaign that targeted struggling children, worried parents, and an army of doctors willing to diagnose and prescribe. And what's worse? The deep-pocketed, pill-pushers are now looking to expand.
For more on this story visit www.commondreams.org
Comments
All kinds of parties want to
All kinds of parties want to keep individuals off of them narcotics. In fact, a number of pharmaceutical businesses are trying to keep individuals off narcotics but specifically generic ones, as a number of “Big Pharma” corporations are using narcotic coupons to keep individuals purchasing brand-name after patents lapsed.